Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Determinants of 25-hydroxyvitamin D Status in a Cutaneous Melanoma Population.
De Smedt J, Van Kelst S, Janssen L, Marasigan V, Boecxstaens V, Stas M, Vanderschueren D, Guler I, Bogaerts K, Vandenberghe K, Bechter O, Billen J, Nikkels A, Strobbe T, Emri G, Lambrechts D, Garmyn M. De Smedt J, et al. Among authors: boecxstaens v. Acta Derm Venereol. 2022 Apr 8;102:adv00692. doi: 10.2340/actadv.v102.262. Acta Derm Venereol. 2022. PMID: 35312026 Free PMC article.
Vitamin D supplementation in cutaneous malignant melanoma outcome (ViDMe): a randomized controlled trial.
De Smedt J, Van Kelst S, Boecxstaens V, Stas M, Bogaerts K, Vanderschueren D, Aura C, Vandenberghe K, Lambrechts D, Wolter P, Bechter O, Nikkels A, Strobbe T, Emri G, Marasigan V, Garmyn M. De Smedt J, et al. Among authors: boecxstaens v. BMC Cancer. 2017 Aug 23;17(1):562. doi: 10.1186/s12885-017-3538-4. BMC Cancer. 2017. PMID: 28835228 Free PMC article. Clinical Trial.
Solar Lentigines are Associated with Better Outcome in Cutaneous Melanoma.
Marasigan V, Güvenç C, Oord JJ, Stas M, Boecxstaens V, Bechter O, Wolter P, Lambrechts D, Garmyn M. Marasigan V, et al. Among authors: boecxstaens v. Acta Derm Venereol. 2019 Jul 17;99(12):1154-1159. doi: 10.2340/00015555-3270. Online ahead of print. Acta Derm Venereol. 2019. PMID: 31314121 Free article.
Corrigendum to "Clinical Presentation, Natural History, and Therapeutic Approach in Patients with Solitary Fibrous Tumor: A Retrospective Analysis".
Schöffski P, Timmermans I, Hompes D, Stas M, Boecxstaens V, Sinnaeve F, De Leyn P, Coosemans W, Van Raemdonck D, Hauben E, Sciot R, Clement P, Bechter O, Beuselinck B, Woei-A-Jin FJSH, Dumez H, Nafteux P, Wessels T. Schöffski P, et al. Among authors: boecxstaens v. Sarcoma. 2021 Jan 29;2021:4653987. doi: 10.1155/2021/4653987. eCollection 2021. Sarcoma. 2021. PMID: 33628084 Free PMC article.
Road to Metastasis: The TWEAK Pathway as a Discriminant between Metastasizing and Non-Metastasizing Thick Melanomas.
Güvenç C, Antoranz A, Szumera-Ciećkiewicz A, Teterycz PP, Rutkowski PR, Rawson RV, Scolyer RA, Thompson JF, Newton-Bishop J, Stas M, Boecxstaens V, Bechter O, Vercauteren J, Garmyn M, van den Oord J, Bosisio FM. Güvenç C, et al. Among authors: boecxstaens v. Int J Mol Sci. 2021 Sep 29;22(19):10568. doi: 10.3390/ijms221910568. Int J Mol Sci. 2021. PMID: 34638912 Free PMC article.
Mapping the Immune Landscape in Metastatic Melanoma Reveals Localized Cell-Cell Interactions That Predict Immunotherapy Response.
Antoranz A, Van Herck Y, Bolognesi MM, Lynch SM, Rahman A, Gallagher WM, Boecxstaens V, Marine JC, Cattoretti G, van den Oord JJ, De Smet F, Bechter O, Bosisio FM. Antoranz A, et al. Among authors: boecxstaens v. Cancer Res. 2022 Sep 16;82(18):3275-3290. doi: 10.1158/0008-5472.CAN-22-0363. Cancer Res. 2022. PMID: 35834277 Free PMC article.
Melanoma cell plasticity poses diagnostic challenges: a case series.
Mennens F, Van Herck Y, Sciot R, Vanden Bempt I, Boecxstaens V, Garmyn M, Bechter O. Mennens F, et al. Among authors: boecxstaens v. Melanoma Res. 2022 Dec 1;32(6):428-439. doi: 10.1097/CMR.0000000000000852. Epub 2022 Sep 20. Melanoma Res. 2022. PMID: 36125893
34 results